Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T04:26:11.174Z Has data issue: false hasContentIssue false

6 - Chronic Pain and its Treatment

Published online by Cambridge University Press:  19 October 2021

Stephen M. Stahl
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Stahl's Self-Assessment Examination in Psychiatry
Multiple Choice Questions for Clinicians
 , pp. 233 - 258
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Ballantyne, JC, Shin, NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 2008;24:469–78.1CrossRefGoogle ScholarPubMed
Clauw, DJ. Fibromyalgia: an overview. Am J Med 2009;122(Suppl 12):S3–13.2Google Scholar

References

McMahon, S, Koltzenburg, M (eds). Wall and Melzack’s textbook of pain, fifth edition. London: Harcourt Publishers; 2005.1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)2Google Scholar
Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapters 3–4)3Google Scholar

References

McMahon, S, Koltzenburg, M (eds). Wall and Melzack’s textbook of pain, fifth edition. London: Harcourt Publishers; 2005.1Google Scholar
Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapter 2)2Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)3Google Scholar

References

Bennett, RM, Friend, R, Marcus, D, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken) 2014;66(9):1364–73.1Google Scholar
Wolfe, F, Clauw, DJ, Fitzcharles, MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62(5):600–10.2Google Scholar

References

Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapter 5)1CrossRefGoogle Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)2Google Scholar

References

Dooley, DJ, Taylor, CP, Donevan, S, Feltner, D. Ca2+ channel alpha 2 delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci 2007;28:75–82.1Google Scholar
Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapter 5)2Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)3Google Scholar

References

Stahl, SM. Stahl’s illustrated chronic pain and fibromyalgia. New York, NY: Cambridge University Press; 2009. (Chapter 2)1CrossRefGoogle Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)2Google Scholar

References

Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology: the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017.2Google Scholar

References

Stahl, SM. Case studies: Stahl’s essential psychopharmacology. New York, NY: Cambridge University Press; 2011.1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 10)2Google Scholar

References

Scholz, BA, Hammonds, CL, Boomershine, CS. Duloxetine for the management of fibromyalgia syndrome. J Pain Res 2009;2:99–108.1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology: the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017.2Google Scholar

References

Stahl, SM, Felker, A. Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants. CNS Spectr 2008;13(10):855–70.1Google Scholar
Wimbiscus, M, Kostenko, O, Malone, D. MAO inhibitors: risks, benefits, and lore. Curr Drug Therapy 2010;77(2):859–82.2Google Scholar

Reference

Abrams, DI, Couey, P, Shade, SB, Kelly, ME, Benowitz, NL. Cannabinoid–opioid interaction in chronic pain. Clin Pharmacol Ther 2011;90(6):844–51.1CrossRefGoogle ScholarPubMed
Andreae, MH, Carter, GM, Shaparin, N, et al. Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data. J Pain 2015;16(12):1221–32.2Google Scholar
Beltramo, M. Cannabinoid type 2 receptor as a target for chronic pain. Mini Rev Med Chem 2009;9(1):11–25.3Google Scholar
National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017. doi:https://doi.org/10.17226/24625.4Google Scholar
Walker, JM, Hohmann, AG, Martin, WJ, Strangman, NM, Huang, SM, Tsou, K. The neurobiology of cannabinoid analgesia. Life Sci 1999;65(6–7):665–73.5Google Scholar
Whiting, PF, Wolff, RF, Deshpande, S et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015;313(24): 2456–73.6Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×